Literature DB >> 17638106

Breast density in relation to risk of ductal carcinoma in situ of the breast in women undergoing screening mammography.

Todd A MacKenzie1, Linda Titus-Ernstoff, Pamela M Vacek, Berta Geller, Julia E Weiss, Martha E Goodrich, Patricia A Carney.   

Abstract

OBJECTIVE: To examine the association between breast density and risk of breast ductal carcinoma in situ (DCIS).
METHODS: We assessed breast density in relation to DCIS risk using combined data from statewide mammography registries in NH and VT. The prospective analyses were based on 572 DCIS cases arising in 154,936 women (58,496 premenopausal and 96,440 postmenopausal). Women in the study were followed on average 4.1 years. Breast density was scored by community radiologists using BIRADS categories (fatty, scattered density, heterogeneous density, extreme density).
RESULTS: In premenopausal women, based on 157 cases, the RR for DCIS risk were 0.29 (95% CI: 0.0.04, 2.24) for fatty breasts, 2.06 (95% CI: 1.39, 3.05) for heterogeneous density, and 2.40 (95% CI: 1.47, 3.91) for extreme density, relative to scattered density. In postmenopausal women, based on 369 cases, the RR for DCIS risk were 0.58 (95% CI: 0.37, 0.93) for fatty breasts, 1.41 (95% CI: 1.12, 1.78) for heterogeneous density, and 1.49 (95% CI: 0.93, 2.37) for extreme density, relative to scattered density. The possible interaction between breast density and menopausal status in relation to DCIS risk was not statistically significant.
CONCLUSIONS: We observed an association between breast density and DCIS risk. Although the association seemed stronger in premenopausal women, there was no evidence of an interaction involving breast density and menopausal status.

Entities:  

Mesh:

Year:  2007        PMID: 17638106     DOI: 10.1007/s10552-007-9035-3

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  7 in total

1.  Comparison of breast density in the contralateral normal breast of patients with invasive and in situ breast cancer measured on MRI.

Authors:  J-H Chen; D Chang; K Nie; F-T Hsu; H-N Shih; C-C Hsu; O Nalcioglu; M-Y Su
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

Review 2.  Epidemiology of ductal carcinoma in situ.

Authors:  Karla Kerlikowske
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 3.  Mammographic density and breast cancer risk: current understanding and future prospects.

Authors:  Norman F Boyd; Lisa J Martin; Martin J Yaffe; Salomon Minkin
Journal:  Breast Cancer Res       Date:  2011-11-01       Impact factor: 6.466

4.  Breast cancer in women younger than 30 years: prevalence rate and imaging findings in a symptomatic population.

Authors:  Dorothy Makanjuola; Abduulmohsen Alkushi; Manal Alzaid; Omalkhair Abukhair; Fatina Al Tahan; Abdulrahman Alhadab
Journal:  Pan Afr Med J       Date:  2014-09-16

5.  Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis.

Authors:  Cecilia W Huo; Mark Waltham; Christine Khoo; Stephen B Fox; Prue Hill; Shou Chen; Grace L Chew; John T Price; Chau H Nguyen; Elizabeth D Williams; Michael Henderson; Erik W Thompson; Kara L Britt
Journal:  Breast Cancer Res       Date:  2016-10-25       Impact factor: 6.466

6.  DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.

Authors:  Kevin C Johnson; Devin C Koestler; Thomas Fleischer; Panpan Chen; Erik G Jenson; Jonathan D Marotti; Tracy Onega; Vessela N Kristensen; Brock C Christensen
Journal:  Clin Epigenetics       Date:  2015-07-25       Impact factor: 6.551

7.  Patient and Provider Perspectives on Mammographic Breast Density Notification Legislation.

Authors:  Elissa V Klinger; Celia P Kaplan; Stella St Hubert; Robyn L Birdwell; Jennifer S Haas
Journal:  MDM Policy Pract       Date:  2016-11-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.